参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/06/21 | 1,952 | 1,975 | 1,947 | 1,956 | -16 | -0.8% | 1,146,000 |
2018/06/20 | 1,947 | 1,972 | 1,935 | 1,972 | +25 | +1.3% | 1,237,600 |
2018/06/19 | 1,980 | 1,999 | 1,946 | 1,947 | -63 | -3.1% | 1,071,200 |
2018/06/18 | 2,049 | 2,049 | 2,003 | 2,010 | -49 | -2.4% | 1,150,900 |
2018/06/15 | 2,010 | 2,061 | 2,000 | 2,059 | +80 | +4% | 2,115,100 |
2018/06/14 | 1,991 | 1,993 | 1,973 | 1,979 | -1 | -0.1% | 1,113,400 |
2018/06/13 | 2,000 | 2,014 | 1,971 | 1,980 | ±0 | ±0% | 1,169,700 |
2018/06/12 | 2,008 | 2,019 | 1,977 | 1,980 | -15 | -0.8% | 1,626,300 |
2018/06/11 | 1,946 | 2,005 | 1,940 | 1,995 | +54 | +2.8% | 1,695,900 |
2018/06/08 | 1,930 | 1,965 | 1,930 | 1,941 | +24 | +1.3% | 1,733,000 |
2018/06/07 | 1,891 | 1,923 | 1,883 | 1,917 | +37 | +2% | 1,476,100 |
2018/06/06 | 1,858 | 1,885 | 1,840 | 1,880 | +8 | +0.4% | 1,499,200 |
2018/06/05 | 1,920 | 1,928 | 1,842 | 1,872 | -67 | -3.5% | 1,971,800 |
2018/06/04 | 1,925 | 1,948 | 1,911 | 1,939 | +38 | +2% | 853,300 |
2018/06/01 | 1,906 | 1,933 | 1,886 | 1,901 | +4 | +0.2% | 1,185,300 |
2018/05/31 | 1,843 | 1,910 | 1,832 | 1,897 | +52 | +2.8% | 4,340,800 |
2018/05/30 | 1,822 | 1,853 | 1,822 | 1,845 | -17 | -0.9% | 1,482,800 |
2018/05/29 | 1,854 | 1,868 | 1,849 | 1,862 | +2 | +0.1% | 733,700 |
2018/05/28 | 1,872 | 1,899 | 1,857 | 1,860 | +3 | +0.2% | 831,500 |
2018/05/25 | 1,871 | 1,888 | 1,854 | 1,857 | -35 | -1.8% | 1,054,400 |
2018/05/24 | 1,860 | 1,895 | 1,856 | 1,892 | +24 | +1.3% | 1,673,900 |
2018/05/23 | 1,887 | 1,889 | 1,859 | 1,868 | -12 | -0.6% | 1,559,500 |
2018/05/22 | 1,880 | 1,895 | 1,866 | 1,880 | -17 | -0.9% | 1,160,200 |
2018/05/21 | 1,942 | 1,942 | 1,884 | 1,897 | -15 | -0.8% | 1,028,000 |
2018/05/18 | 1,903 | 1,921 | 1,888 | 1,912 | +24 | +1.3% | 1,074,000 |
2018/05/17 | 1,898 | 1,929 | 1,873 | 1,888 | -9 | -0.5% | 1,505,300 |
2018/05/16 | 1,892 | 1,903 | 1,874 | 1,897 | ±0 | ±0% | 1,371,600 |
2018/05/15 | 1,910 | 1,913 | 1,887 | 1,897 | -3 | -0.2% | 1,397,800 |
2018/05/14 | 1,890 | 1,911 | 1,882 | 1,900 | +15 | +0.8% | 1,328,600 |
2018/05/11 | 1,891 | 1,898 | 1,847 | 1,885 | -41 | -2.1% | 1,926,300 |
2018/05/10 | 1,837 | 1,930 | 1,828 | 1,926 | +122 | +6.8% | 1,786,000 |
2018/05/09 | 1,840 | 1,845 | 1,790 | 1,804 | -62 | -3.3% | 1,256,800 |
2018/05/08 | 1,860 | 1,891 | 1,858 | 1,866 | +16 | +0.9% | 974,300 |
2018/05/07 | 1,848 | 1,864 | 1,818 | 1,850 | +21 | +1.1% | 791,300 |
2018/05/02 | 1,840 | 1,841 | 1,799 | 1,829 | -6 | -0.3% | 1,039,500 |
2018/05/01 | 1,815 | 1,844 | 1,804 | 1,835 | -10 | -0.5% | 1,408,600 |
2018/04/27 | 1,830 | 1,854 | 1,830 | 1,845 | +26 | +1.4% | 929,100 |
2018/04/26 | 1,813 | 1,827 | 1,804 | 1,819 | +16 | +0.9% | 860,500 |
2018/04/25 | 1,785 | 1,816 | 1,785 | 1,803 | +10 | +0.6% | 685,500 |
2018/04/24 | 1,764 | 1,797 | 1,764 | 1,793 | +37 | +2.1% | 891,100 |
2018/04/23 | 1,760 | 1,762 | 1,720 | 1,756 | -8 | -0.5% | 929,000 |
2018/04/20 | 1,768 | 1,781 | 1,763 | 1,764 | -9 | -0.5% | 681,900 |
2018/04/19 | 1,807 | 1,814 | 1,766 | 1,773 | -23 | -1.3% | 950,500 |
2018/04/18 | 1,781 | 1,805 | 1,777 | 1,796 | +13 | +0.7% | 890,000 |
2018/04/17 | 1,772 | 1,800 | 1,771 | 1,783 | +32 | +1.8% | 1,435,500 |
2018/04/16 | 1,723 | 1,754 | 1,712 | 1,751 | +44 | +2.6% | 1,248,700 |
2018/04/13 | 1,765 | 1,771 | 1,706 | 1,707 | -51 | -2.9% | 1,191,600 |
2018/04/12 | 1,744 | 1,771 | 1,744 | 1,758 | +17 | +1% | 872,200 |
2018/04/11 | 1,769 | 1,771 | 1,730 | 1,741 | -17 | -1% | 1,135,800 |
2018/04/10 | 1,776 | 1,805 | 1,751 | 1,758 | -10 | -0.6% | 1,292,000 |
1751~
1800
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 157,500円 | -2.0% | -7.3% | 2.41% | 15.39倍 | 1.83倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ロート | 253,900円 | +8.4% | +6.4% | 1.65% | 18.21倍 | 2.21倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
住友ファーマ | 144,000円 | -11.0% | +206.6% | 0.00% | 14.30倍 | 3.38倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
久光薬 | 429,900円 | +5.8% | +1.2% | 2.79% | 13.92倍 | 1.11倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ツムラ | 364,900円 | +3.8% | -19.9% | 3.73% | 11.85倍 | 0.91倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム